Breaking News

Labcorp Completes Acquisition of BioReference Health Assets

The $225 million acquisition includes BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services.

Author Image

By: Charlie Sternberg

Associate Editor

Labcorp, a global provider of comprehensive laboratory services, has completed its previously announced acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. This acquisition includes BioReference Health’s laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States. The transaction also includes certain customer accounts and other operating assets. The purchase price for the transac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics